ODDB.org: Open Drug Database

Irinotecan Fresenius 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung -

Swissmedic Key	61246019	Registration Holder	Fresenius Kabi (Schweiz) AG
Name	Irinotecan Fresenius 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung	Date of registration	28.01.2011
Original/Generic	Generic	Introduction of Sequence	28.01.2011
ATC-Classification	Irinotecan (L01XX19)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	07.16.10.	Show package size
Index Therapeuticus (Swissmedic)	07.16.10.	Description
Swissmedic categorie.	A
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	245.64	Limitation	No

Deductible	10 %	Consumer price	283.55
Feedback	FB
GTIN	7680612460190	Medication Code	Synthetika
Pharmacode	7738397	Disponibility

Composition

irinotecani hydrochloridum trihydricum 300 mg, sorbitolum 675 mg, acidum lacticum, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 15 ml.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	300mg / 15ml

BAG: Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	300 mg

Inactive agents	Dose
Acidum Hydrochloridum ad Ph
Lactic Acid
Natrii Hydroxidum ad Ph
Sorbitol	675mg / 15ml

Source

Data was imported : 11.07.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH